U.S. Construction Stock News

Interest rates sit at 3.9%, long-term yields hover above 5%, and inflation still eats into paychecks, so cash is no longer a forgotten corner of the market. Short-duration income vehicles now compete hard for attention, as higher yields reshape where investors park their money and how they think about risk. This article unpacks 3 US-listed stocks exposed to that rate story and explains why their positioning could matter for your portfolio. The three US stocks in this piece are a starting...

CNO Financial Group (CNO) has drawn investor attention after its recent share price of US$55.21, with returns over the past month and past three months contrasting shorter term daily moves. Recent trading has cooled slightly, with the 1-day share price return declining 0.65% and the 7-day share price return edging down 0.58%. Even so, CNO Financial Group still shows building momentum when you zoom out, supported by a 30.83% year-to-date share price return and a 40.87% total shareholder return...

Weis Markets (WMK) is under closer investor scrutiny after a voluntary recall of its Fresh From the Orchard pasteurized apple cider, following an FDA enforcement report citing high patulin levels in multiple batches. Weis Markets shares trade at US$72.26 after a modest 30-day share price return of 1.77%. However, the share price is still down 8.53% over 90 days as momentum has cooled, following earlier gains that left the year-to-date share price return at 12.71% and the 5-year total...

MasTec was recently added to the FTSE All-World Index in US dollars, following a period of strong demand across power delivery, data centers, and renewable energy infrastructure that has supported double-digit revenue growth and a record backlog in key divisions. The index inclusion increases MasTec's visibility with global investors at the same time its grid modernization and clean energy work is shaping longer-term project pipelines and revenue visibility. We will explore how MasTec's...

Strategy (MSTR) has been in the spotlight after a 16% jump that coincided with a Bitcoin rally and fresh crypto friendly regulatory moves in Washington, putting its concentrated Bitcoin treasury approach back under the microscope. At a share price of $153.92, Strategy has seen a 1-day share price return of 16.4% and a 30-day share price return of 29.1%, alongside fresh Bitcoin friendly moves in Washington. However, the year-to-date share price return is slightly down 2.1% and the 1-year total...

AI data centers now absorb more real money than new homes in the U.S., and hyperscalers are planning around US$1.3b in annual capex by 2027 to feed that buildout. Power, grid gear, and electrification sit right on that fault line between opportunity and potential overbuild. This article breaks down how that backdrop touches three U.S. Power Grid and Electrification Providers to Data Centers stocks that are exposed to the same news shock. The three stocks in focus below are only a small...

The Federal Reserve just lifted interest rates again to tackle inflation that sits at 3.4%, and money is no longer cheap. Growth stories now face a simple test: Can the business justify its price when borrowing costs bite? That is exactly where fast expanding companies with leaders who own a lot of their own stock can shine. This article breaks down three such high conviction ideas from our screener. The three stocks covered below are just a sample of this theme, with the full screen...

Tariff headlines are back in focus, and that matters for your portfolio. When imported goods face extra charges, cost pressure can ripple through global supply chains while companies rooted in local manufacturing and distribution may feel that shock very differently. That gap in exposure can create both opportunity and risk. This article walks through three stocks exposed to the latest trade story and how each might fit into your watchlist. The stocks covered below are just a starting sample,...

The Federal Reserve’s latest rate increase highlights how expensive human labor and borrowing have become, while spending on AI data centers and automation hardware keeps climbing. That mix is turning real world robotics into a practical way for companies to control costs and protect margins. This article walks through three leading automation stocks from our screener that are aligned with that trend and merit closer examination at this time. The stocks covered below are only a small sample,...

Aptiv was removed from the FTSE All-World Index (USD) in September 2026, a change that can trigger portfolio reshuffling by index-tracking funds. The fair value estimate cut to US$66.61 highlights how questions around auto sector headwinds and execution risks are intersecting with Aptiv’s long-term software and electrification ambitions. We will now examine how Aptiv’s investment narrative could be affected by its FTSE All-World exit and the lower fair value estimate. Pressure test Aptiv’s...

Oil prices just slipped about 1.7–1.8% as traders wager that Saudi crude shipments will recover, even while Middle East risks refuse to fade into the background. That mix of softer prices today and the threat of sharp spikes later can reshuffle winners and losers across fuel intensive sectors. This article unpacks how that backdrop ties into three stocks from our Global Oil Importing Sectors Sensitive to Lower Crude Prices screener that could be meaningfully exposed to this news. The stocks...

With the Fed’s policy rate now at 3.9% and the 10 year Treasury yield near 5%, cash and short term bonds suddenly compete hard with riskier assets, while inflation keeps investors on edge. That mix is reshaping where capital flows. This article examines three stocks tied to short duration U.S. Treasury and TIPS ETFs that appear aligned with this rate backdrop, and outlines how the recent news may affect each one. The issuers highlighted below are a small sample, and the full screen surfaced...

Lear (LEA) is drawing attention after recent trading left the share price at US$120.64, with the auto supplier reporting annual revenue of US$23.7b and net income of US$556.0m. Recent trading has been choppy for Lear, with the share price falling 1.69% over the last session and down 6.39% across the past week. A 1.71% year to date share price gain contrasts with a 20.00% total shareholder return over twelve months, indicating that dividends and past buybacks have contributed more than recent...

Fed officials are keeping short-term rates high and signaling they could stay there, which keeps cash, T‑bills, and short‑duration bond yields in sharp focus for every investor trying to park money without going all in on long-term risk. That backdrop creates real FOMO around which providers may benefit from persistent demand for parking cash. This article walks through three stocks exposed to that rate story and explains why the latest Fed messaging matters for each one. The three stocks in...

Gaming and Leisure Properties has seen a mixed share price record, with the stock giving investors a positive 15.8% total return over the past 5 years but slipping over the shorter term. That combination highlights a straightforward question for you as a shareholder or prospective buyer: whether today's valuation can be explained by the earnings the business produces. The 15.8% gain over 5 years shows that long term holders have seen progress, which now raises the issue of whether the...

Western Midstream Partners (WES) has drawn attention after a recent move in the units, with the price finishing at US$47.29. Investors are weighing this level against performance over the past month and the past 3 months. Short term momentum for Western Midstream Partners has cooled, with the share price down 3.6% over the past week and 2.2% over the past month. However, the 19.1% year to date share price return and very strong multi year total shareholder returns suggest longer term buyers...

CRISPR Therapeutics (NasdaqGM:CRSP) heads into the Morgan Stanley 24th Annual Global Healthcare Conference on 14 September 2026, giving investors fresh context for a gene editing pipeline that spans hemoglobinopathies, CAR T therapies and type 1 diabetes. Over the past week, CRISPR Therapeutics has seen a 7-day share price return of 9.36%, even though the 1-month share price return is down 4.94%. The 1-year total shareholder return has declined 9.24%, while the 3-year total shareholder return...

Signet Jewelers (SIG) is back in focus after reporting a return to profitability in its second quarter, reaffirming sales guidance and pairing those updates with a renewed credit partnership and ongoing capital returns. That return to profit has arrived alongside a strong rebound in momentum, with a 30-day share price return of 23.4% and a 90-day gain of 15.7% helping lift Signet Jewelers to US$100.38. The 3-year total shareholder return of 42.8% tells a longer story of improving sentiment...

Ecolab (ECL) is set to address investors at Morgan Stanley's 14th Annual Laguna Conference on 15 September 2026, where it will offer fresh commentary on its water, hygiene and infection prevention operations. Ecolab shares trade at US$269.46 after easing 4.3% over the past month and 2.4% over the last week, while a 1 year total shareholder return of 2.6% contrasts with a much stronger 3 year total shareholder return of 61.6%. This suggests earlier momentum has cooled ahead of the upcoming...

Ameris Bancorp (ABCB) has declared a quarterly dividend of $0.20 per share, payable on October 5, 2026, to shareholders of record as of September 30, 2026. Ameris Bancorp’s latest dividend decision comes after a steady run this year, with a year-to-date share price return of 12.87%. This is despite a 3.13% decline over the past 30 days and a 4.42% decline over the past 90 days. Compare Ameris Bancorp’s income focus with other hand-picked banks and financials that pair steady payouts with...

Vipshop Holdings (NYSE:VIPS) sits in focus after a recent share price slide, with the stock down over the past month and past 3 months, inviting closer scrutiny from value oriented investors. Over the past year, momentum in Vipshop Holdings has clearly cooled, with the share price down 30.49% year to date and the 1-year total shareholder return also declining 30.34%. However, the 5-year total shareholder return of 13.60% points to a far more resilient long run picture. Scan beyond Vipshop...

Ameren has issued callable, subordinated fixed to floating rate notes due March 15, 2057, raising US$900 million in unsecured corporate debt. The company has also presented at the Barclays 40th Annual Energy-Power Conference in New York. This combination of long dated, junior funding and public engagement with institutional investors indicates active balance sheet planning around future infrastructure and grid investment needs. We will examine how Ameren's investment narrative around long...

Patterson-UTI Energy (PTEN) has come into focus after its shares closed at US$11.78, with a reported 129.8% total return over the past year despite the company posting a loss. In the short term, the share price has pulled back, with a 7 day share price return of down 8.33% and a 1 month share price return of down 4.54%. However, Patterson-UTI Energy still shows strong momentum, with an 82.07% year to date share price return and a 129.77% 1 year total shareholder return. Scan beyond...

Elevance Health (ELV) used its appearance at the Wells Fargo 21st Annual Healthcare Conference on 10 September 2026 to reinforce its earnings outlook and cost discipline, keeping the recent valuation conversation very much alive. Recent trading has been mildly soft, with the share price down 0.8% on the day and 1.9% over the past week. Even so, Elevance Health still carries a 16.0% year to date share price return and a 33.6% 1 year total shareholder return, indicating that momentum has cooled...